Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series E raises whopping $89mm for ConforMIS; expands round to $167.7mm

Executive Summary

ConforMIS Inc. (orthopedic implants) pulled in $89mm in its Series E financing round to private equity funds from the US, Europe, Asia, and the Middle East. Lead investors were AGC Equity Partners, Axel Johnson, and government investment funds from Asia and the UAE. The money will support sales and marketing activities and scaled-up manufacturing for its knee replacement systems. The company stands to receive additional milestone-based funds.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies